ORCL.NYSEOracle CORP

Form 4: Oracle Director George H. Conrades Reports Stock Option Exercise and Share Sale

Sentiment:

SEC Form 4 Filing


Director George H. Conrades exercised stock options and sold 25,000 shares of Oracle (ORCL) common stock on May 1, 2024.

Summary

  • On May 1, 2024, George H. Conrades, a director of Oracle Corp, exercised stock options to acquire 25,000 shares of common stock at a price of $42.02 per share.
  • Concurrently, Conrades sold 25,000 shares of Oracle common stock at a weighted average price of $116.1276 per share, in multiple trades ranging from $116.00 to $116.29.
  • Following these transactions, Conrades directly owns 17,836 shares of Oracle common stock and 20,000 derivative securities.

Sentiment

Score: 5

Explanation: The document is a neutral report of insider trading activity, with no inherent positive or negative sentiment.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, providing transparency into the trading activities of company executives and directors. It is common for executives to exercise stock options and sell shares for personal financial management.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders due to the change in ownership, but the overall effect is likely negligible.

Key Dates

DateDescription
06/04/2019Power of Attorney filed for Aimee Weast to act as Attorney in Fact for George H. Conrades
05/01/2024Earliest transaction date: Exercise of stock options and sale of common stock.
05/01/2024Stock options exercisable.
05/31/2024Expiration date of stock options.
05/02/2024Date of Form 4 signature.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.